why does nobody talk about tendon
The title is the whole question — why does nobody talk about tendon — but here is why I am asking. Kept a reconstituted vial too long out of curiosity and learned something about solution stability I would rather have read. Assumed regulatory status was static and it was not. Checked again this year and the answer…
It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.
Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.
It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test r
Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.
Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.
Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.
a fifteen-residue peptide is easy to make and easy to make badly
What jurisdiction are you asking about? The answer has changed in several.